In the most recent quarter (Q3), Evelo Biosciences reported EPS of $-0.71, beating estimates of $-0.78 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Evelo Biosciences has averaged an EPS surprise of 0.22% and a revenue surprise of 0.00%.
Analyze the earnings history of Evelo Biosciences using advanced sorting and filters.
The chart below shows Evelo Biosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Evelo Biosciences's reported revenue compared to analyst estimates over recent quarters.
Evelo Biosciences (EVLO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3.
Evelo Biosciences (EVLO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual EPS was $-0.71, which beat the estimate of $-0.78.
Evelo Biosciences (EVLO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-09 | $-0.71 | $-0.78 | 8.97 % |
| Q2 | 2023-08-14 | $-3.78 | $-3.30 | -14.5 % |
| Q1 | 2023-05-15 | $-4.60 | $-3.30 | -39.4 % |
| Q4 | 2023-03-16 | $-4.20 | $-5.60 | 25.0 % |